Pregnancy and inflammatory bowel disease in Greece: A prospective study of seven cases in a single hospital setting

Annals of Gastroenterology

Volumn 20, Issue 1, 2007, Pages 29-34

  Triantafillidis, John K ^a,b   Malgarinos, G ^a   Gikas, A ^a   Delicha, Evi ^a   Giannakoulopoulou, Eleftheria ^a   Stamataki, Asteria ^a   Fouskas, J ^a   Mastrangelis, A ^a   Georgopoulos, F ^a   Cherakakis, P ^a   Papadimitriou, A ^a  

^a Saint Panteleimon General State Hospital   (Greece)

^b NONE   (Greece)

Author keywords

Crohn's disease; Inflammatory bowel disease; Outcome; Pregnancy; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; MESALAZINE;

ADULT; ARTICLE; BIRTH WEIGHT; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; FETUS DEATH; FOLLOW UP; GREECE; HUMAN; NEWBORN DISEASE; PREGNANCY; PREMATURE LABOR; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

EID: 34548526746     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Triantafillidis JK, A. Emmanouilidis, O.N. Manousos, E. Pomonis, C. Tsitsa, P. Cheracakis, Ch. Barbatzas. Ulcerative colitis in Greece: clinicoepidemiological date, course and prognostic factors in 413 consecutive patients. J Clin Gastroenterol 1998; 27:204-210.
2. Sela HY, Rojansky N, Hershko AY. Reproduction and ulcerative colitis: a review. J Reprod Med 2005; 50:361-366.
3. Triantafillidis J.K, A. Emmanouilidis, O. Manousos, D. Nicolakis, M. Kogevinas. Clinical patterns of Crohn's disease in Greece: a follow-up study of 155 cases. Digestion 2000; 61:121-128.
4. Agret F, Cosnes J, Hassani Z, Gornet JM, Gendre JP, Lemann M, Beaugerie L. Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther 2005; 21:509-513.
5. Katz JA. Pregnancy and inflammatory bowel disease. Curr Opin Gastroenterol 2004; 20:328-32.
6. Riis L, Vind I, Politi P, Wolters F, et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2006; 101:1539-1545.
7. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2002; 97:641-648.
8. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004; 15:237-241.
9. Norgard B, Puho E, Pedersen L, Czeizel AE, Sorensen HT. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol. 2003; 98:2006-2010.
10. Dozois EJ, Wolff BG, Tremaine WJ, Watson WJ, Drelichman ER, Carne PW, Bakken JL. Maternal and fetal outcome after colectomy for fulminant ulcerative colitis during pregnancy: case series and literature review. Dis Colon Rectum 2006; 49:64-73.
11. Ravid A, Richard CS, Spencer LM, O'Connor BI, Kennedy ED, MacRae HM, Cohen Z, McLeod RS. Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2002; 45:1283-1288.
12. Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E, Present DH. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 2004;99:656-661.
13. Norgard B, Czeizel AE, Rockenbauer M, Olsen J, Sorensen Hr. Population-based case control study of the safety of sulfasalazine use during pregriancy. Aliment Pharmacol Ther 2001; 15:483-486.
14. Norgard B, Fonager K, Pedersen L, Jacobsen BA, Sorensen HT. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003; 52:243-247.
15. de Boer NY, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol. 2006; 101:1390-1392.
16. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003; 124:9-17.
17. Norgard B, Pedersen L, Fonager K, Rasmussen SN, Sorensen HT. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 2003; 17:827-834.
18. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K,, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005; 21:733-8.
19. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99:2385-2392.